Skip to main content

Table 3 Univariate analysis of clinical parameters with GA, GA/HbA1c, and HbA1c in HD patients without DM

From: Inverse correlation of free triiodothyronine with glycated albumin and the glycated albumin/glycated hemoglobin ratio in hemodialysis patients: a cross-sectional study

non-DM

GA

GA/HbA1c

HbA1c

r

P

r

P

r

P

Av-PG

0.380

0.002

0.203

0.103

0.354

0.004

HbA1c

0.146

0.241

− 0.329

0.007

  

GA/HbA1c

0.884

< 0.001

  

− 0.329

0.007

FT3

− 0.511

< 0.001

− 0.514

< 0.001

0.053

0.673

Age

0.355

0.003

0.254

0.040

0.189

0.129

Men(= 1)/Women(= 0)

− 0.017

0.894

− 0.085

0.498

0.139

0.268

Hb

− 0.285

0.021

− 0.254

0.040

− 0.006

0.963

Alb

− 0.271

0.028

− 0.184

0.138

− 0.197

0.114

BMI

− 0.423

< 0.001

− 0.582

< 0.001

0.399

< 0.001

GNRI

− 0.405

< 0.001

− 0.446

< 0.001

0.091

0.469

ChE

− 0.393

0.001

− 0.351

0.004

− 0.036

0.777

Cr

− 0.228

0.065

− 0.191

0.125

− 0.095

0.449

P

− 0.362

0.003

− 0.361

0.003

0.027

0.831

T.Chol

− 0.191

0.125

− 0.099

0.427

− 0.181

0.146

Log CRP

− 0.029

0.815

− 0.111

0.374

0.206

0.097

HD duration

0.201

0.106

0.310

0.012

− 0.247

0.045

ESA dose

0.277

0.024

0.219

0.078

0.082

0.512

  1. GA, Glycated albumin; HbA1c, glycated hemoglobin; HD, hemodialysis; DM, diabetes mellitus; r, correlation coefficient; Av-PG, average plasma glucose; FT3, free triiodothyronine; Hb, hemoglobin; Alb, albumin; BMI, body mass index; GNRI, Geriatric Nutritional Risk Index; ChE, cholinesterase; Cr, creatinine; P, phosphate; T.Chol, total cholesterol; CRP, C-reactive protein; ESA, erythropoiesis-stimulating agent